SEDDAIU, Maria Antonietta
 Distribuzione geografica
Continente #
NA - Nord America 2.881
AS - Asia 1.760
EU - Europa 1.082
SA - Sud America 884
AF - Africa 57
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.675
Nazione #
US - Stati Uniti d'America 2.793
BR - Brasile 788
SG - Singapore 690
CN - Cina 548
UA - Ucraina 319
DE - Germania 154
VN - Vietnam 141
SE - Svezia 114
HK - Hong Kong 106
FR - Francia 95
IT - Italia 94
GB - Regno Unito 88
FI - Finlandia 66
TR - Turchia 53
CZ - Repubblica Ceca 41
CA - Canada 40
IQ - Iraq 34
IN - India 29
AR - Argentina 28
MX - Messico 27
RU - Federazione Russa 25
BE - Belgio 24
ID - Indonesia 20
BD - Bangladesh 18
EC - Ecuador 17
ZA - Sudafrica 17
VE - Venezuela 16
JP - Giappone 15
PK - Pakistan 14
UZ - Uzbekistan 14
CO - Colombia 12
PL - Polonia 12
JO - Giordania 11
IR - Iran 10
MA - Marocco 10
ES - Italia 9
LT - Lituania 9
PY - Paraguay 9
AT - Austria 8
AZ - Azerbaigian 8
KR - Corea 8
KE - Kenya 7
NL - Olanda 7
AU - Australia 6
AE - Emirati Arabi Uniti 5
NP - Nepal 5
PA - Panama 5
SA - Arabia Saudita 5
TN - Tunisia 5
BG - Bulgaria 4
CH - Svizzera 4
CL - Cile 4
HN - Honduras 4
PE - Perù 4
UY - Uruguay 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
MY - Malesia 3
PH - Filippine 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BO - Bolivia 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
JM - Giamaica 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
EE - Estonia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
UG - Uganda 1
Totale 6.675
Città #
Dallas 863
Singapore 413
Chandler 370
San Jose 194
Jacksonville 191
Ashburn 118
Beijing 110
Hong Kong 105
Princeton 96
Nanjing 76
Dearborn 75
Ann Arbor 69
Sassari 57
Wilmington 52
São Paulo 50
Ho Chi Minh City 47
Lauterbourg 45
Rio de Janeiro 39
Brno 38
Los Angeles 38
Nanchang 37
Hanoi 35
Santa Clara 35
Boardman 34
Shanghai 32
Izmir 27
Munich 26
Woodbridge 26
Changsha 25
Shenyang 25
Brussels 24
Tianjin 21
London 20
Baghdad 16
New York 16
The Dalles 16
Belo Horizonte 15
Tokyo 15
Toronto 15
Zhengzhou 15
Brasília 14
Council Bluffs 14
Jiaxing 14
Columbus 13
Hebei 13
Helsinki 13
Jinan 13
Porto Alegre 13
Tashkent 13
Campinas 12
Orem 12
Warsaw 12
Amman 11
Hangzhou 11
Nuremberg 11
Chennai 10
Falls Church 10
Ningbo 10
Augusta 9
Boston 9
Frankfurt am Main 9
Guarulhos 9
Johannesburg 9
Mexico City 9
Salvador 9
San Francisco 9
Ardabil 8
Baku 8
Denver 8
Goiânia 8
Guangzhou 8
Leawood 8
Norwalk 8
Quito 8
San Mateo 8
Santo André 8
Seoul 8
Stockholm 8
Turku 8
Andover 7
Biên Hòa 7
Brooklyn 7
Buffalo 7
Da Nang 7
Guayaquil 7
Istanbul 7
Nairobi 7
Ribeirão Preto 7
Taizhou 7
Chicago 6
Contagem 6
Curitiba 6
Fortaleza 6
Ipatinga 6
Joinville 6
Kunming 6
Monmouth Junction 6
Montreal 6
Mountain View 6
Ottawa 6
Totale 4.052
Nome #
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 215
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 191
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 186
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 184
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 183
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 181
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 176
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 176
INHIBITION OF 3-HYDROXY-3-METHYLGLUTARY-COA REDUCTASE ACTIVITY AND GENE EXPRESSION BY DEHYDROEPIANDROSTERONE IN PRENEOPLASTIC LIVER NODULES 170
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 158
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 157
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 157
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 157
Experimental models to define the genetic predisposition to liver cancer 157
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 155
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 153
Chemopreventive N-(4-hidroxyphenyl)retinamide targets NF-kB and Mat1A genes in early stages of rat liver carcinogenesis. 152
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 152
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 148
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 146
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 145
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 144
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 142
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 139
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 138
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 138
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 137
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: is DNA methylation involved? 134
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 131
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 131
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 130
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 128
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 128
Frequent loss of heterozygosity at the Hcr1 (Hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain 128
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 126
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 125
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 120
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 118
The post-transcriptional dysregulation of methionine adenosyl-transferases is crucial for the progression of rat and human liver cancer. 47° Annual Meeting of the European Association for Study of the Liver (EASL) Aprile 18-22, 2012 108
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 108
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 108
Inhibition of 3-hydroxy-3- methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneolastic liver nodules 105
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 99
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis 99
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 95
Modulation of P16INK4A activity by Hsp90, Cdc37 and CRM1 influences the progression of preneoplastic lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 90
Reversal by 5-azacytidine of the s-adenosyl-L-methionine induced inhibition of the development of putative preneoplastic foci in rat-liver 89
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. 45° Annual Meeting of the European Association for the Study of the Liver (EASL) Aprile 14-18, 2010 83
Totale 6.720
Categoria #
all - tutte 25.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.708


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022270 44 1 1 5 4 7 20 11 26 22 30 99
2022/2023632 67 64 13 120 51 106 0 69 109 1 19 13
2023/2024162 29 13 1 5 19 3 0 4 0 1 22 65
2024/20251.648 13 20 64 61 77 53 115 314 509 290 92 40
2025/20262.548 134 609 433 299 228 150 332 67 99 132 61 4
Totale 6.720